» Articles » PMID: 21944935

Surveillance of Transfusion-transmissible Infections Comparison of Systems in Five Developed Countries

Overview
Specialty Hematology
Date 2011 Sep 28
PMID 21944935
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Most industrialized countries maintain surveillance programs for monitoring transmissible infection in blood donations, revising approaches to methodology and risk assessment as new threats emerge. A comparison of programs in the United States, Canada, France, the UK, and Australia indicates that they have similar function, although the structure of blood programs vary as does the extent and nature of formal ties with public health. The emergence of HIV in the late 1970s and early 1980s was key in recognizing that surveillance systems specific to blood transfusion were essential. Hence, most industrialized countries monitor transfusion-transmissible infections in donors and evaluate the impact of new testing and of predonation screening strategies. Emerging infections since HIV have had different transmission pathways and challenged blood programs to draw upon resources for a rapid and effective response, with recognition that the original focus on sexual/drug-related risk of HIV and hepatitis was inadequate. The focus of surveillance programs on new and emerging pathogens fulfills a key role in risk assessment and policy formulation. The precise nature of such activities varies by country because of the structure of the blood programs and surveillance systems, the strategic focus of the blood programs, and the epidemiology of disease in each country.

Citing Articles

Hepatitis B Blood Donor Screening Data: An Under-Recognized Resource for Canadian Public Health Surveillance.

OBrien S, Reedman C, Osiowy C, Bolotin S, Yi Q, Lourenco L Viruses. 2023; 15(2).

PMID: 36851623 PMC: 9966614. DOI: 10.3390/v15020409.


Molecular and serological detection of occult hepatitis B virus among healthy hepatitis B surface antigen-negative blood donors in Malaysia.

Hudu S, Harmal N, Saeed M, Alshrari A, Malik Y, Niazlin M Afr Health Sci. 2016; 16(3):677-683.

PMID: 27917199 PMC: 5111975. DOI: 10.4314/ahs.v16i3.6.


Malaysian child infected with Plasmodium vivax via blood transfusion: a case report.

Anthony C, Lau Y, Sum J, Fong M, Ariffin H, Zaw W Malar J. 2013; 12:308.

PMID: 24007496 PMC: 3846159. DOI: 10.1186/1475-2875-12-308.


Molecular virology in transfusion medicine laboratory.

Candotti D, Allain J Blood Transfus. 2013; 11(2):203-16.

PMID: 23356973 PMC: 3626471. DOI: 10.2450/2012.0219-12.

References
1.
Davison K, Dow B, Barbara J, Hewitt P, Eglin R . The introduction of anti-HTLV testing of blood donations and the risk of transfusion-transmitted HTLV, UK: 2002-2006. Transfus Med. 2009; 19(1):24-34. DOI: 10.1111/j.1365-3148.2008.00902.x. View

2.
OBrien S, Fan W, Ram S, Goldman M, Nair R, Chiavetta J . Face-to-face interviewing in predonation screening: lack of effect on detected human immunodeficiency virus and hepatitis C virus infections. Transfusion. 2006; 46(8):1380-7. DOI: 10.1111/j.1537-2995.2006.00906.x. View

3.
Kleinman S, Lelie N, Busch M . Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion. Transfusion. 2009; 49(11):2454-89. DOI: 10.1111/j.1537-2995.2009.02322.x. View

4.
Epstein J, Holmberg J . Progress in monitoring blood safety. Transfusion. 2010; 50(7):1408-12. DOI: 10.1111/j.1537-2995.2010.02728.x. View

5.
Seed C, Kiely P, Law M, Keller A . No evidence of a significantly increased risk of transfusion-transmitted human immunodeficiency virus infection in Australia subsequent to implementing a 12-month deferral for men who have had sex with men. Transfusion. 2010; 50(12):2722-30. DOI: 10.1111/j.1537-2995.2010.02793.x. View